In this population-based cohort study, researchers compared the risks of incident cardiovascular, neurological, and mental health conditions and rheumatoid arthritis in a year following COVID hospitalization to three different groups: pre-pandemic hospitalization for influenza, pre-pandemic hospitalization for sepsis and hospitalization for sepsis post-pandemic.
Risks associated with COVID-19 infection after hospitalization are similar to those associated with other infectious diseases like sepsis and the flu, according to a recent study published in JAMA Network.
Researchers of the study found that venous thromboembolic disease was the only condition post-hospitalization to occur at comparable rates in those hospitalized for sepsis and the flu.
It’s been reported that it’s unclear how post-hospitalization risks for COVID compare with those of other serious infectious illnesses, as those who survive COVID hospitalization are known to be at risk for developing new cardiovascular, neurological, mental health and inflammatory autoimmune conditions.
In this population-based cohort study, researchers compared the risks of incident cardiovascular, neurological, and mental health conditions and rheumatoid arthritis in a year following COVID hospitalization to three different groups: pre-pandemic hospitalization for influenza, pre-pandemic hospitalization for sepsis and hospitalization for sepsis post-pandemic.
Participants of the study were made of adults 18 and older in Ontario, Canada who were hospitalized with COVID-19 between April 1, 2020, and October 31, 2021, and followed up for up to 1 year after hospitalization. Participants with for flu or sepsis were hospitalized between January 1, 2014, and March 25, 2019, and those with sepsis during the pandemic were hospitalized between April 1, 2020, and October 31, 2021.
There were insufficient flu cases during the pandemic to form a full comparison. The index study date was the date of discharge from hospital.
Of the 379,366 participants, 26,499 survived COVID-19 hospitalization. Of the historical controls, 17,516 had the flu and 282,473 had sepsis. Those with sepsis monitored during the pandemic made up 52,878 of the participants.
Hospitalization for COVID-19 was associated with an increased 1-year risk of venous thromboembolic disease compared with the flu but had no increase for the other post-acute conditions.
The rates of serious medical and mental health conditions following hospitalization for COVID-19, flu, or sepsis suggest that many of these conditions may be related to the severity of illness from any infection resulting to hospitalization, rather than being directly associated to COVID-19 infection.
Findings from the study contrast with prior research, which reported that COVID-19 was associated with substantially increased risks of multiple long-term health outcomes. Though, these associations may have been overestimated due to the choice of comparator groups in some studies.
Latest Vaccines and Antiviral Treatments Show Promising Results in Reducing Severe COVID Outcomes
March 7th 2024It was found in a recent study that the updated Moderna, Pfizer-BioNTech and Novavax COVID-19 vaccines, when combined with antiviral treatments like nirmatrelvir and molnupiravir, can significantly decrease the chances of hospitalization and death from current COVID-19 variants.
Read More
In this episode, Peter Wehrwein, managing editor of Managed Healthcare Executive, speaks with Dr. Rodrigo Cerda. Dr. Cerda has been recently promoted to the position of senior vice president of health services and chief medical officer of Independence Blue Cross in Philadelphia. He is also a member of Managed Healthcare Executive’s editorial advisory board. Peter and Dr. Cerda discuss his new role at the Independence Blue Cross, what it means to be a chief medical officer at an insurer these days, valued-based care, social determinants of health, and, of course, the pandemic.
Listen
How More Prompt Action Could Have Saved Thousands of U.S. COVID-19 Deaths
December 10th 2023Researchers of a study compared Israel's CVOID-19 booster rollout experience to the United States to ask the question: How many lives could the U.S. have saved if boosters were authorized sooner?
Read More
Briana Contreras, associate editor of MHE, spoke with Dr. Maria Hernandez, founder and CEO of Impact4Health. Maria shared not only how healthcare inequities remain to be an issue and what needs to be addressed, but also the progress that has been made over time through awareness, conversations and laws, especially due to the heightened awareness of inequities caused from the COVID-19 pandemic and the tragic deaths of George Floyd, Breonna Taylor and many more - which have now occurred over a year ago.
Listen
A Cup or Two of Joe a Day Could Keep COVID-19 Infection Away
November 19th 2023Coffee, rich in polyphenolic compounds like chlorogenic acid (CGA), caffeic acid (CAA), cafestol, melanoidins and trigonelline, has been recognized as a dominant source of CGA in various studies. Previous studies suggest that CGA in coffee can positively impact blood pressure, lipid profile, glycemia and insulin resistance.
Read More
The Challenges, Strategies of COVID-19 Misinformation Interventions
November 16th 2023COVID-19 misinformation interventions should involve public health experts, establish consistent outcome measures and more to address health misinformation at individual, community and systems levels, according researchers of a recent study.
Read More